Skip to main content
BLFS
NASDAQ Industrial Applications And Services

10% Shareholder Casdin Partners Files New $15.6M Stock Sale Intent

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Instrument Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$24.74
Mkt Cap
$1.209B
52W Low
$17.86
52W High
$29.62
52W Position info
39% above low
Off High info
16% below high
Rel. Volume info
2.3× avg
Market data snapshot near publication time

BLFS sits 39% above its 52-week low of $17.86 on elevated volume (2.3× avg).

Summary

A 10% shareholder, Casdin Partners, has filed a new Form 144 to sell $15.6 million in BioLife Solutions stock, continuing a pattern of significant dispositions.


Key Events · Ownership and Investor Activity · BLFS

  • Major Shareholder Intent to Sell

    Casdin Partners, a 10% shareholder, intends to sell 650,000 shares of common stock, valued at approximately $15.6 million, on or after May 21, 2026.

  • Continuation of Recent Sales

    This filing follows previous Form 144s from Casdin Partners, which reported sales of 550,000 shares for $12.72 million over the past three months, including sales on May 19th and May 20th.

  • Significant Stake Reduction

    The proposed sale represents approximately 1.33% of the company's outstanding shares, indicating a continued reduction in holdings by a major institutional investor.


Analysis · BLFS · Industrial Applications And Services

Casdin Partners, a major institutional investor and 10% shareholder, has filed a new Form 144 indicating its intent to sell an additional $15.6 million worth of BioLife Solutions common stock. This follows previous Form 144 filings from Casdin Partners, which reported sales of $12.72 million over the past three months, including sales on May 19th and May 20th. The continued significant selling pressure from a major institutional holder could weigh on investor sentiment, despite the company's recent positive financial results.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, BLFS was trading at $24.74 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $1.2B. The 52-week trading range was $17.86 to $29.62. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

BLFS - Latest Insights

BLFS
Oct 06, 2026, 9:11 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $39.00
Real-time Price: $39.00 info
Change: $0 (0%) info
Market Cap: $1.889B info
BLFS
Sep 30, 2026, 6:01 AM EDT
Filing Type: 425
Importance Score:
7
Price at Filing: $39.33
Real-time Price: $39.00 info
Change: -$0.330 (-0.84%) info
Market Cap: $1.889B info
BLFS
Sep 30, 2026, 6:01 AM EDT
Filing Type: DEFA14A
Importance Score:
7
Price at Filing: $39.33
Real-time Price: $39.00 info
Change: -$0.330 (-0.84%) info
Market Cap: $1.889B info
BLFS
Sep 09, 2026, 5:22 PM EDT
Filing Type: DEFA14A
Importance Score:
8
Price at Filing: $34.93
Real-time Price: $39.00 info
Change: +$4.07 (+12%) info
Market Cap: $1.889B info
BLFS
Sep 09, 2026, 5:21 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $34.93
Real-time Price: $39.00 info
Change: +$4.07 (+12%) info
Market Cap: $1.889B info